Back to search
FDAFDA · Food and drugs·Recall number Z-2184-2012

IMPAX Cardiovascular (CV) Reporting Reporting tool used for structured reporting and structured report outputs (including XML style sheet customization and PDF)

Published August 22, 2012 · Recall initiated: July 27, 2012

Summary

FDA records medical device Class II recall Z-2184-2012, published August 22, 2012 and initiated July 27, 2012. Recalling firm: AGFA Corp.; Status: Terminated; Reported quantity: 280; Lot: Model # L9M2100 - All Software versions of IMPAX CV Reporting. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Content entered into the "Conclusions" free text box on the Report Writer screen was not represented on the final printed report.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AGFA Corp.
Distributor
Worldwide Distribution - USA (nationwide) and Canada
Lot
Model # L9M2100 - All Software versions of IMPAX CV Reporting
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was IMPAX Cardiovascular (CV) Reporting Reporting tool used for structured reporting and structured report outputs (including XML style sheet customization and PDF) recalled?

Yes. FDA published recall Z-2184-2012 on August 22, 2012. Reported hazard: Content entered into the "Conclusions" free text box on the Report Writer screen was not represented on the final printed report.

What should I do if I have this product?

Voluntary: Firm initiated · Letter